Welcome to the

National Institutes of Health
Commercialization Assistance Program (CAP)
For Phase II SBIR Awardees

(Managed by Larta Institute)

Applications no longer accepted! / Program Selection: September 27, 2011
Submit your application

Selections will be announced by the end of September 2011. The following competency areas will be considered in the evaluation and selection of participants into the program:

Commercialization Goals of Company: 

• Clear commercial goals and strong likelihood of attaining commercial goals
• Critical milestones achieved in anticipation of commercial entry: e.g. FDA approval
• Progress to date in achieving commercial success
• Experience of the team or the principal contact at the Company
• Understanding of, and experience working with, potential partners or investors
• Knowledge of, and exposure to, commercialization as a process and discipline
• Expression of commercialization goals, both near- and long-term
• Alignment of expressed goals with needs

Business Case Strength:

• The intellectual property (IP) status of the SBIR-funded technology and of the business itself.
• The underlying strength of this technology, as indicated by expressed interest by end-users and partners
• Identification and understanding of the obstacles, gaps and deficiencies of the technology and the business and timeframe to resolve them
• Available resources (current and future) to fill gaps and accomplish goals